arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

USANA HEALTH SCIENCES INC

USNA
$15.45 ▲ +0.58 (+3.90%) at close
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
18 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
56
Health
Fair
Neutral
auto_awesome

Analytical Summary

USANA HEALTH SCIENCES INC shows mixed fundamentals. Consider comparing against peers in the Materials sector before making investment decisions.

Market Cap $286.4M
Dividend Yield
Revenue Growth 8.3%
Op. Margin 4.0%
ROIC 1.9%
FCF / Share $0.46
Trailing P/E 26.6x
Price / Book 0.5x
FCF Yield 3.0%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$925.26M
↑ +8.3%
Net Income Profit after all expenses
$10.76M
↓ -74.4%
Operating Margin Operating profit as % of sales
4.0%
↓ -47.9% 40th
FCF / Share Free cash flow per share
$0.46
↓ -82.7%

Health Breakdown

Profitability
34
Returns
47
Financial Health
94
Cash Quality
53

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters